Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 1
2009 1
2010 2
2012 3
2013 1
2014 1
2015 2
2016 2
2018 4
2020 3
2021 5
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome.
Pagnotta S, Tramutola A, Barone E, Di Domenico F, Pittalà V, Salerno L, Folgiero V, Caforio M, Locatelli F, Petrini S, Butterfield DA, Perluigi M. Pagnotta S, et al. Among authors: folgiero v. Free Radic Biol Med. 2022 Apr;183:1-13. doi: 10.1016/j.freeradbiomed.2022.03.006. Epub 2022 Mar 11. Free Radic Biol Med. 2022. PMID: 35283228 Review.
AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation.
Caforio M, Tumino N, Sorino C, Manni I, Di Giovenale S, Piaggio G, Iezzi S, Strimpakos G, Mattei E, Moretta L, Fanciulli M, Vacca P, Locatelli F, Folgiero V. Caforio M, et al. Among authors: folgiero v. Front Immunol. 2023 Jun 26;14:1191908. doi: 10.3389/fimmu.2023.1191908. eCollection 2023. Front Immunol. 2023. PMID: 37435061 Free PMC article.
Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention.
Lanzillotta C, Zuliani I, Tramutola A, Barone E, Blarzino C, Folgiero V, Caforio M, Valentini D, Villani A, Locatelli F, Butterfield DA, Head E, Perluigi M, Abisambra JF, Di Domenico F. Lanzillotta C, et al. Among authors: folgiero v. Prog Neurobiol. 2021 Jan;196:101892. doi: 10.1016/j.pneurobio.2020.101892. Epub 2020 Aug 11. Prog Neurobiol. 2021. PMID: 32795489
Upfront treatment with mTOR inhibitor everolimus in pediatric low-grade gliomas: A single-center experience.
Cacchione A, Lodi M, Carai A, Miele E, Tartaglia M, Megaro G, Del Baldo G, Alessi I, Colafati GS, Carboni A, Boccuto L, Diomedi Camassei F, Catanzaro G, Po A, Ferretti E, Pedace L, Pizzi S, Folgiero V, Pezzullo M, Corsetti T, Secco DE, Cefalo MG, Locatelli F, Mastronuzzi A. Cacchione A, et al. Among authors: folgiero v. Int J Cancer. 2021 May 15;148(10):2522-2534. doi: 10.1002/ijc.33438. Epub 2020 Dec 27. Int J Cancer. 2021. PMID: 33320972 Free article.
Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children.
Lanzillotta C, Greco V, Valentini D, Villani A, Folgiero V, Caforio M, Locatelli F, Pagnotta S, Barone E, Urbani A, Di Domenico F, Perluigi M. Lanzillotta C, et al. Among authors: folgiero v. Antioxidants (Basel). 2020 Nov 11;9(11):1112. doi: 10.3390/antiox9111112. Antioxidants (Basel). 2020. PMID: 33187268 Free PMC article.
29 results